NCT03775265: An ongoing trial by National Cancer Institute (NCI)
This trial is ongoing. It must report results 1 year, 12 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT03775265 |
|---|---|
| Title | Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 3, 2019 |
| Completion date | June 1, 2027 |
| Required reporting date | May 31, 2028, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | June 3, 2026 |
| Days late | None |